Macrophages participate in both the debridement and reparative phases of the self-resolving inflammatory response. During the debridement phase, these cells synthesize and secrete a number of inflammatory mediators including hydrolytic enzymes that collectively degrade the connective tissue matrix, while in the repair phase, macrophages secrete growth factors and cytokines that stimulate the proliferation of mesenchymal and epithelial cells, and influence the extent to which these latter cells deposit elements of the new connective tissue matrix. How these divergent macrophage activities are regulated is largely unknown. Based on our own preliminary data and other indications in the literature, we hypothesize that these discrete macrophage activities are manifested through the sequential expression of two distinct macrophage """"""""phenotypes"""""""": a """"""""degradative"""""""" phenotype, defined by the increased synthesis of lysosomal enzymes such as beta-glucuronidase, and a putative """"""""reparative"""""""" phenotype, defined by an increased level of expression of fibrogenic growth factors such as IGF-1, IL-1beta, fibronectin and TGFbeta. The objectives of this proposal are threefold: Firstly, to investigate the mechanisms that control the expression of the """"""""degradative"""""""" macrophage phenotype and to define the mechanism of induction of this state by PDGF. Secondly, to determine the mechanism leading to the cessation of expression of the """"""""degradative"""""""" state and the proposed ensuing induction of expression of the """"""""reparative"""""""" state. Thirdly, we propose to determine the level of expression of macrophage genes in healthy individuals, and patients with interstitial lung diseases (e.g. interstitial pulmonary fibrosis) or with a predisposition to develop this disorder (e.g. progressive systemic sclerosis). Alveolar macrophages will be analyzed for the expression of multiple phenotype associated genes (including PDGF-B, IGF-1, IL-8, TNFalpha, complement Bf and fibronectin) using a quantitative polymerase chain reaction assay. In addition, we propose to begin to address the question of the functions of the interstitial macrophage in the pathology of interstitial lung diseases. Collectively, these investigations are expected to shed new light onto the mechanism(s) of macrophage involvement in tissue degradation and repair especially in the context of lung diseases in man.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL027353-13
Application #
3758239
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
13
Fiscal Year
1994
Total Cost
Indirect Cost
Name
National Jewish Health
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Kinder, Brent W; Brown, Kevin K; McCormack, Francis X et al. (2009) Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest 135:1557-1563
Kinder, Brent W; Brown, Kevin K; Schwarz, Marvin I et al. (2008) Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosis. Chest 133:226-32
Perez, Rafael L; Kimani, Anthony P; King Jr, Talmadge E et al. (2007) Bronchoalveolar lavage fluid D dimer levels are higher and more prevalent in black patients with pulmonary sarcoidosis. Respiration 74:297-303
Schwarz, Marvin I; Albert, Richard K (2004) ""Imitators"" of the ARDS: implications for diagnosis and treatment. Chest 125:1530-5
Vourlekis, Jason S; Schwarz, Marvin I; Cool, Carlyne D et al. (2002) Nonspecific interstitial pneumonitis as the sole histologic expression of hypersensitivity pneumonitis. Am J Med 112:490-3
Inoue, Yoshikazu; King Jr, Talmadge E; Barker, Elizabeth et al. (2002) Basic fibroblast growth factor and its receptors in idiopathic pulmonary fibrosis and lymphangioleiomyomatosis. Am J Respir Crit Care Med 166:765-73
King Jr, T E; Schwarz, M I; Brown, K et al. (2001) Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality. Am J Respir Crit Care Med 164:1025-32
King Jr, T E; Tooze, J A; Schwarz, M I et al. (2001) Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am J Respir Crit Care Med 164:1171-81
Glazer, C S; Cohen, L B; Schwarz, M I (2001) Acute eosinophilic pneumonia in AIDS. Chest 120:1732-5
Martinez, J A; Nishimura, C; Guatura, S B et al. (2001) Elevation of soluble interleukin-2 receptor levels in the bronchoalveolar lavage from patients with systemic sclerosis. Rheumatol Int 21:122-6

Showing the most recent 10 out of 220 publications